Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis

被引：0
|
作者：
Anthony, D. C.
Campbell, S. J.
Seneca, N.
Balazs, M.
Leppert, D.
机构：
[1] Univ Oxford, Oxford, England
[2] Roche, Basel, Switzerland
[3] Genentech Inc, San Francisco, CA 94080 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P734
引用
收藏
页码：S325 / S326
页数：2
相关论文
共 50 条
  • [41] Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
    Apostolidis, Sokratis A.
    Kakara, Mihir
    Painter, Mark M.
    Goel, Rishi R.
    Mathew, Divij
    Lenzi, Kerry
    Rezk, Ayman
    Patterson, Kristina R.
    Espinoza, Diego A.
    Kadri, Jessy C.
    Markowitz, Daniel M.
    Markowitz, Clyde E.
    Mexhitaj, Ina
    Jacobs, Dina
    Babb, Allison
    Betts, Michael R.
    Prak, Eline T. Luning
    Weiskopf, Daniela
    Grifoni, Alba
    Lundgreen, Kendall A.
    Gouma, Sigrid
    Sette, Alessandro
    Bates, Paul
    Hensley, Scott E.
    Greenplate, Allison R.
    Wherry, E. John
    Li, Rui
    Bar-Or, Amit
    NATURE MEDICINE, 2021, 27 (11) : 1990 - +
  • [42] Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
    Sokratis A. Apostolidis
    Mihir Kakara
    Mark M. Painter
    Rishi R. Goel
    Divij Mathew
    Kerry Lenzi
    Ayman Rezk
    Kristina R. Patterson
    Diego A. Espinoza
    Jessy C. Kadri
    Daniel M. Markowitz
    Clyde E. Markowitz
    Ina Mexhitaj
    Dina Jacobs
    Allison Babb
    Michael R. Betts
    Eline T. Luning Prak
    Daniela Weiskopf
    Alba Grifoni
    Kendall A. Lundgreen
    Sigrid Gouma
    Alessandro Sette
    Paul Bates
    Scott E. Hensley
    Allison R. Greenplate
    E. John Wherry
    Rui Li
    Amit Bar-Or
    Nature Medicine, 2021, 27 : 1990 - 2001
  • [43] Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
    Anthony, D. C.
    Sibson, N. R.
    Losey, P.
    Piani, D.
    Leppert, D.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S275 - S276
  • [44] Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis
    Tacke, Sabine
    Chunder, Rittika
    Schropp, Verena
    Urich, Eduard
    Kuerten, Stefanie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [45] Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy
    Woopen, Christina
    Dunsche, Marie
    Al Rahbani, Georges Katoul
    Dillenseger, Anja
    Atta, Yassin
    Haase, Rocco
    Raposo, Catarina
    Pedotti, Rosetta
    Ziemssen, Tjalf
    Akgun, Katja
    VACCINES, 2023, 11 (09)
  • [46] Assessing B-cell depletion and disease activity in a french multiple sclerosis cohort treated by long-term anti-CD20 antibody therapy
    Freeman, S.
    Lemarchant, B.
    Alberto, T.
    Drelon, A.
    Boucher, J.
    Dubucquoi, S.
    Zephir, H.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 355 - 356
  • [47] Relative frequency of CD11c+peripheral blood B cells increases after anti-CD20 monoclonal antibody therapy in relapsing-remitting multiple sclerosis
    El Mahdaoui, Sahla
    Hansen, Marie Mathilde
    von Essen, Marina Rode
    Hvalkof, Victoria
    Sellebjerg, Finn
    Christensen, Jeppe Romme
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 235 - 236
  • [48] Disease Modifying Therapy Choice in People with Multiple Sclerosis in The Era of Covid: Characterizing Outcomes in Patients who Switched from anti-CD20 Therapies to Diroximel Fumarate
    Kaczmarek, O.
    Sethi, A.
    Teng, E.
    Bumstead, B.
    Buhse, M.
    Zarif, M.
    Scott, N.
    Gocke, A.
    Mendoza, J. P.
    Gudesblatt, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 78 - 79
  • [49] Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy
    Freeman, Sean A.
    Lemarchant, Bruno
    Alberto, Tifanie
    Boucher, Julie
    Outteryck, Olivier
    Labalette, Myriam
    Rogeau, Stephanie
    Dubucquoi, Sylvain
    Zephir, Helene
    NEUROTHERAPEUTICS, 2023, 20 (06) : 1707 - 1722
  • [50] Assessing Sustained B-Cell Depletion and Disease Activity in a French Multiple Sclerosis Cohort Treated by Long-Term IV Anti-CD20 Antibody Therapy
    Sean A. Freeman
    Bruno Lemarchant
    Tifanie Alberto
    Julie Boucher
    Olivier Outteryck
    Myriam Labalette
    Stéphanie Rogeau
    Sylvain Dubucquoi
    Hélène Zéphir
    Neurotherapeutics, 2023, 20 : 1707 - 1722
12345